August 30, 2024 09:14 PM EDTUpdated September 3, 06:20 AM
Pharma
FDA+
Coronavirus

FDA au­tho­rizes No­vavax's up­dat­ed Covid boost­er

Nicole DeFeudis

Editor

The FDA has au­tho­rized emer­gency use of No­vavax’s up­dat­ed Covid boost­er, just over a week af­ter clear­ing up­dat­ed ver­sions of mR­NA boost­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

GSK, iTeos re­ju­ve­nate strug­gling TIG­IT space with pos­i­tive Phase 2 Jem­per­li com­bo da­ta in lung can­cer

#ES­MO24 roundup: New da­ta on Am­gen’s PRMT5 in­hibitor seem lack­lus­ter, and Jazz’s HER2 an­ti­body

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

Post-Hoc: Big promis­es built Mod­er­na. They might al­so be its un­do­ing

Ex­clu­sive: A male con­tra­cep­tive may pre­vent 99% of preg­nan­cies. Now it’s up to a small biotech to fin­ish test­ing it

A service from the Financial Times